Greener Pharmaceuticals' Regulatory Highway
Call for action on regulatory support for introduction of more sustainable products and services
23 December 2024
| Technical document
Overview
As climate change continues to exacerbate health risks worldwide, modern health systems, contributing to approximately 5% of global carbon emissions, must prioritize sustainability.
WHO, through its Department of Regulation and Prequalification, has issued a call for action urging global regulatory bodies and stakeholders in the pharmaceutical and healthcare industries to adopt innovative practices that prioritize sustainability and reduce environmental impact.
WHO Team
Access to Medicines and Health Products (MHP)